Sonosalpingography After Hysteroscopic Tubal Occlusion

See also
Status	Clinical Trial	Phase
Completed	`NCT04071392` - Development of an Intrauterine Pressure Threshold to Confirm Tubal Occlusion
Completed	`NCT04077242` - Hysteroscopic Evaluation of Fallopian Tubal Patency	N/A
Recruiting	`NCT02698644` - Hysteroscopic Tubal Occlusion With the Use of Iso Amyl-2-cyanoacrylate	Phase 1

See also

Status

Clinical Trial

Phase

Completed

NCT04071392 - Development of an Intrauterine Pressure Threshold to Confirm Tubal Occlusion

Completed

NCT04077242 - Hysteroscopic Evaluation of Fallopian Tubal Patency

N/A

Recruiting

NCT02698644 - Hysteroscopic Tubal Occlusion With the Use of Iso Amyl-2-cyanoacrylate

Phase 1

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03116867
Study type	Observational
Source	Ain Shams University
Contact	Sherif H Hussain, MD
Phone	0201005219239
Email	docsherif77@yahoo.com
Status	Recruiting
Phase	N/A
Start date	May 2017
Completion date	April 2018

Sonosalpingography After Hysteroscopic Tubal Occlusion

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms